These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15608532)

  • 21. Hospitalization in HIV in Chicago.
    Sherer R; Pulvirenti J; Stieglitz K; Narra J; Jasek J; Green L; Moore B; Shott S; Cohen M
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(1):26-33. PubMed ID: 12942666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy.
    Wilson IB; Landon BE; Ding L; Zaslavsky AM; Shapiro MF; Bozzette SA; Cleary PD
    Med Care; 2005 Jan; 43(1):12-20. PubMed ID: 15626929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital and outpatient health services utilization among HIV-infected patients in care in 1999.
    HIV Research Network
    J Acquir Immune Defic Syndr; 2002 May; 30(1):21-6. PubMed ID: 12048359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of antiretroviral use in the United States of America: analysis of three observational databases.
    Ghani AC; Donnelly CA; Anderson RM
    HIV Med; 2003 Jan; 4(1):24-32. PubMed ID: 12534956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.
    Weintrob AC; Grandits GA; Agan BK; Ganesan A; Landrum ML; Crum-Cianflone NF; Johnson EN; Ordóñez CE; Wortmann GW; Marconi VC;
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):574-80. PubMed ID: 19755913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.
    Levine RS; Briggs NC; Kilbourne BS; King WD; Fry-Johnson Y; Baltrus PT; Husaini BA; Rust GS
    Am J Public Health; 2007 Oct; 97(10):1884-92. PubMed ID: 17761583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States.
    Daumit GL; Crum RM; Guallar E; Powe NR; Primm AB; Steinwachs DM; Ford DE
    Arch Gen Psychiatry; 2003 Feb; 60(2):121-8. PubMed ID: 12578429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
    McGowan CC; Weinstein DD; Samenow CP; Stinnette SE; Barkanic G; Rebeiro PF; Sterling TR; Moore RD; Hulgan T
    PLoS One; 2011 Apr; 6(4):e18462. PubMed ID: 21541016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in antiretroviral prescribing for blacks and whites in the United States.
    Oramasionwu CU; Skinner J; Ryan L; Frei CR
    J Natl Med Assoc; 2009 Nov; 101(11):1140-4. PubMed ID: 19998643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons.
    Carrico AW; Bangsberg DR; Weiser SD; Chartier M; Dilworth SE; Riley ED
    AIDS; 2011 May; 25(8):1113-8. PubMed ID: 21399478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.
    Knowlton AR; Arnsten JH; Eldred LJ; Wilkinson JD; Shade SB; Bohnert AS; Yang C; Wissow LS; Purcell DW
    AIDS Patient Care STDS; 2010 Jul; 24(7):421-8. PubMed ID: 20578910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in the use of drug therapy for HIV disease in an urban community.
    Moore RD; Stanton D; Gopalan R; Chaisson RE
    N Engl J Med; 1994 Mar; 330(11):763-8. PubMed ID: 8107743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics.
    Sackoff JE; McFarland JW; Shin SS
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):178-83. PubMed ID: 10737433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.
    Thorsteinsson K; Ladelund S; Jensen-Fangel S; Johansen IS; Katzenstein TL; Pedersen G; Storgaard M; Obel N; Lebech AM
    BMC Infect Dis; 2012 Nov; 12():293. PubMed ID: 23140254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
    Mengist HM; Taye B; Tsegaye A
    PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.
    Haines CF; Fleishman JA; Yehia BR; Lau B; Berry SA; Agwu AL; Moore RD; Gebo KA
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):340-347. PubMed ID: 27763997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.
    Giordano TP; Bartsch G; Zhang Y; Tedaldi E; Absalon J; Mannheimer S; Thomas A; MacArthur RD
    AIDS Patient Care STDS; 2010 May; 24(5):287-95. PubMed ID: 20438378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.